Rapidx Bio
Medical and Diagnostic Laboratories
Cambridge, Cambridgeshire, UK 176 followers
From Symptom to Treatment in Minutes for Infectious Disease Using Ultrafast Plasmonic PCR For Unprocessed Sample Testing
About us
Problem 1.4+ billion people are diagnosed with infectious diseases every year. 8 days is the average delay for a person to go from the first symptom to treatment leading to severe disease, causing 15 million+ avoidable deaths every year. We have developed an infectious disease detection technology that can reduce this symptom-to-treatment cycle from the 8 day average to under 30 minutes. How Our Technology Works And Its USP Our prototype uses fingernail sized lasers and gold nanorods to amplify pathogen DNA to provide unprocessed sample-to-result time of <5 minutes. Crucially, the plasmonic PCR process integrates/removes the need for crucial steps (such as cell lysis, extraction and purification) to detect pathogens from entirely unprocessed samples, enabling it to be used without the need for a healthcare professional or a technician. Using our fast, single-step, portable and high accuracy PCR, first in point-of-care settings and subsequently in point-of-need or patient-facing settings, we can help diagnose and treat patients 200x faster (from 8 days to a few mins) to prevent severe disease.
- Website
-
https://rapidx.bio/
External link for Rapidx Bio
- Industry
- Medical and Diagnostic Laboratories
- Company size
- 2-10 employees
- Headquarters
- Cambridge, Cambridgeshire, UK
- Type
- Privately Held
Locations
-
Primary
Maxwell Centre
Cavendish Laboratory
Cambridge, Cambridgeshire, UK CB3 0HE, GB